Results 81 to 90 of about 659,528 (297)

Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control

BMC Medicine, 2018
BackgroundThe seven-valent pneumococcal conjugate vaccine (PCV) was introduced in England in September 2006, changing to the 13-valent vaccine in April 2010.
D. Thorrington, N. Andrews, J. Stowe, E. Miller, A. V. van Hoek   +4 more
semanticscholar   +1 more source

Vaccination in dermatology 2025: Update considering current recommendations of the German Standing Committee on Vaccination

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The immunosuppressive and immunomodulatory treatment of dermatological patients necessitates the regular review and updating of standard vaccinations and vaccines indicated for specific conditions. The German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute regularly publishes evidence‐based vaccination recommendations ...
Johanna Stoevesandt, Marc Schmalzing, Sophia Mohme, Matthias Goebeler   +3 more
wiley   +1 more source

Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq

International Journal of General Medicine, 2023
Ali Al-Jumaili,1 Haider N Dawood,2 Delan Ikram,3 Ali Al-Jabban3 1Pediatric Department, Central Pediatric Teaching Hospital, Baghdad, Iraq; 2Internal Medicine Department, Al-Imamain Al-Kadhimin Medical City, Baghdad, Iraq; 3Medical Department, Pfizer ...
Al-Jumaili A, Dawood HN, Ikram D, Al-Jabban A   +3 more
doaj  

Pneumococcal vaccine and opsonic pneumococcal antibody [PDF]

Journal of Infection and Chemotherapy, 2013
Streptococcus pneumoniae is a major human pathogen responsible for the majority of bacterial pneumonia cases as well as invasive pneumococcal diseases with high mortality and morbidity. Use of conjugate vaccines targeting the pneumococcal capsule has dramatically reduced the incidence of invasive diseases, and there are active efforts to further ...
Robert L. Burton, Joon Young Song, Joon Young Song, M. Allen Moseley, Moon H. Nahm   +4 more
openaire   +3 more sources

Immunogenicity of 13-Valent Conjugate Pneumococcal Vaccine in Patients 50 Years and Older with End-Stage Renal Disease and on Dialysis

Clinical and Vaccine Immunology, 2016
Patients with end-stage renal disease (ESRD) and on dialysis are at increased risk of pneumococcal disease. We evaluated the immunogenicity of the 13-valent pneumococcal conjugate vaccine (PCV13) in this population.
Subhashis Mitra, G. Stein, Shyam Bhupalam, D. Havlichek   +3 more
semanticscholar   +1 more source

Adults aged 65 years and older in South Africa have a responsibility to vaccinate against influenza

Developing World Bioethics, EarlyView.
Abstract In this article, we draw on the thinking about incompleteness and conviviality grounded in Afro‐communitarianism ethics from the Global South to argue that adults aged 65 years and above have a prima facie responsibility to vaccinate against influenza.
Ruach Sarangarajan, Cornelius Ewuoso
wiley   +1 more source

Analysis of pneumococcal vaccination status and its influencing factors among young and middle-aged populations: an online survey

Zhongguo gonggong weisheng
ObjectiveTo understand the pneumococcal vaccination status and its influencing factors among young and middle-aged populations, and provide reference for promoting pneumococcal vaccination.
Ziying CHEN, Sijia ZHOU, Xin JIANG, Wen LIU, Yuhang MA, Kai WANG, Zhixiang DAI, Shuhan TANG, Chengxi ZHENG, Jianli HU, Zhihang PENG   +10 more
doaj   +1 more source

Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution

Expert Review of Vaccines, 2018
Introduction: Pneumococcal conjugate vaccine (PCV) impact studies have reported substantial reductions in the incidence of invasive pneumococcal disease (IPD) after implementation of childhood PCV programs.
P. Izurieta, Priti Bahety, R. Adegbola, Christopher Clarke, B. Hoet   +4 more
semanticscholar   +1 more source

Vaccination in Multiple Myeloma: Challenges and Strategies

European Journal of Haematology, EarlyView.
ABSTRACT Background Multiple myeloma (MM) is a hematological malignancy characterized by profound immunosuppression resulting from both disease‐related mechanisms and treatment‐induced immune dysfunction. This compromised immune status markedly increases susceptibility to infections, a leading cause of morbidity and mortality in MM patients.
Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Santino Caserta, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

PNEUMOCOCCAL INFECTION. IMMUNIZATION BY A 7-VALENT CONJUGATED PNEUMOCOCCAL VACCINE OF CHILDREN BORN TO HIV-POSITIVE WOMEN

Вопросы современной педиатрии, 2011
The article contains pneumococcal infection prevalence survey among HIV-positive children. Questions of pneumococcal infection prevention using pneumococcal conjugated vaccine are discussed in the article.
L.Yu Afoninа, E.E. Voronin, Yu.A. Fomin, Yu.V. Lobzin   +3 more
doaj   +2 more sources